New antifungal drug could shield liver transplant patients from deadly infections
Disease control
ENROLLING_BY_INVITATION
This study tests whether a new antifungal drug called rezafungin can prevent serious fungal infections in liver transplant patients who are at high risk. About 385 adult liver transplant recipients will receive the drug, and their infection rates will be compared to similar patie…
Phase: PHASE3 • Sponsor: Fernanda P Silveira, MD, MS • Aim: Disease control
Last updated May 07, 2026 18:43 UTC